Swiss AI innovator b-rayZ has achieved a significant milestone in the field of breast diagnostics with the receipt of the CE mark for its groundbreaking DANAI technology. This marks a revolution in AI-powered medical imaging solutions, specifically tailored for breast cancer detection, density assessment, and quality-controlled breast positioning.
DANAI is seamlessly integrated into the comprehensive breast diagnostic suites known as b-box plus, and represents a paradigm shift in AI technology. It leverages its adaptability to dynamically meet the unique needs of different breast imaging institutions and their professional staff. By calibrating to the distinct requirements of each imaging unit, DANAI enhances diagnostic accuracy and streamlines operational efficiencies.
Prof. Dr. Cristina Rossi, CEO of b-rayZ, expressed her excitement over this accomplishment and said, The CE mark for DANAI is a tribute to our commitment to innovation and excellence in breast imaging. With this achievement, b-rayZ becomes the first company to cover the entire mammography workflow, closing the last gap in the adoption of AI in all clinical settings with Custom AI capabilities. This innovation revolutionizes the diagnostic landscape through our commitment to the highest quality breast cancer diagnostics.
The launch of the DANAI technology is scheduled to take place in the coming weeks, alongside a grand showcase at the European Congress of Radiology (ECR) 2024 in Vienna. This event will provide industry professionals with an exclusive opportunity to experience firsthand the transformative capabilities and adaptability of DANAI in diverse clinical settings.
DANAI is set to redefine AI capabilities, offering a revolutionary custom AI framework that ensures optimal adaptability, safety, precision, and efficiency in diagnostic processes. This launch represents a pivotal moment in advancing the field of medical imaging, setting new standards for excellence and innovation.
b-rayZ specializes in AI solutions dedicated to breast cancer diagnostics. Their tailored ecosystem of solutions supports women throughout their diagnostic journey, providing a comprehensive set of industry-leading AI modules. Designed to meet the needs of medical professionals, these modules support the daily work of medical radiology assistants, radiologists, and hospital managers.
For those interested in learning more about b-rayZ or the new DANAI technology, personal demos can be booked through their website.
In conclusion, b-rayZ’s receipt of the CE mark for its DANAI technology is a major achievement that will transform breast diagnostics. With its adaptability and custom AI framework, DANAI promises to enhance diagnostic accuracy and streamline operational efficiencies. This innovation represents a significant milestone in the field of medical imaging and sets new standards for excellence.
